Advertisement

Medizinische Klinik

, Volume 92, Issue 11, pp 675–679 | Cite as

Das CONSORT-Statement

Empfehlungen zur Berichterstattung über randomisierte klinische Studien
  • J. Köbberling
  • Wilhelm Gaus
  • Franz Porzsolt
Standorte
  • 41 Downloads

Literatur

  1. 1.
    Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial: survey of 71 “negative” trials. N Engl J Med 1978; 299:690–4.PubMedGoogle Scholar
  2. 2.
    Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994;272:122–4.PubMedCrossRefGoogle Scholar
  3. 3.
    The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994;272:1926–31. Correction: JAMA 1995;273:776.CrossRefGoogle Scholar
  4. 4.
    Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature: a position paper. Ann Intern Med 1994;121:894–5.Google Scholar
  5. 5.
    Rennie D. Reporting randomized controlled trials: an expertment and a call for responses from readers. JAMA 1995;273:1054–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Williams JW Jr, Holleman DR Jr, Samsa GP, Simel DL. Randomized controlled trials of 3 vs 10 days of trimethoprim/ suifamethoxazole for acute maxillary sinusitis. JAMA 1995;273:1015–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. Br Med J 1994;309:1286–91.Google Scholar
  8. 8.
    Ad Hoc Working Group for Critical Appreisal of the Medical Literature. Aproposal for more informative abstracts of clinicsi studies. Ann Intern Med 1987;106:598–604.Google Scholar
  9. 9.
    Taddio A, Pain T, Fassos FF, Boon H, Hiersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articies in the British, Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. Can Med Assoc J 1994;150:1611–5.Google Scholar
  10. 10.
    Oxman AD, Guyatt GH. A consumer’s guide to subgroup analyses. Ann Intern Med 1992;116:78–84.PubMedGoogle Scholar
  11. 11.
    Godfrey K. Statistics in practice: comparing the means of several groups. N Engl J Med 1985;313:1450–6.PubMedGoogle Scholar
  12. 12.
    Gardner MJ, Bond J. An exploratory study of statistical assessment of papers published in the British Medical Journal. JAMA 1990;263:1355–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 1991;10:1595–605.PubMedCrossRefGoogle Scholar
  14. 14.
    Pocock SJ. When to stop a clinical trial. Br Med J 1992; 305:235–40.CrossRefGoogle Scholar
  15. 15.
    Donner A, Brown KS, Brasher P. A methodological review of nontherapeutic intervention trials employing cluster randomization, 1979–1989. Int J Epidemiol 1990; 19:795–800.PubMedCrossRefGoogle Scholar
  16. 16.
    Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994;272:125–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Schulz KF, Subverting randomization in controlled trials. JAMA 1995;274:1456–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Schulz KF, Grimes DA, Altman DG, Hayes RJ Blinding and exclusion after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. Br Med J 1996;312:742–4.Google Scholar
  20. 20.
    Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM. Ascorbic acid for the common cold: a prophylactic and therapeutic trial. JAMA 1975;231: 1038–42.PubMedCrossRefGoogle Scholar
  21. 21.
    Pocock SJ. Clinical trials: A practical approach. Chichester, England: John Wiley & Sons Inc, 1983:182–6.Google Scholar
  22. 22.
    Bailar JC, Mosteller F. Guidelines for statistical reporting in articies for medical journals. Ann Intern Med 1988; 108:266–73.PubMedGoogle Scholar
  23. 23.
    Gardner MJ, Altmann DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 1986;292:746–50.CrossRefGoogle Scholar
  24. 24.
    Evans M, Pollock AV. Trials on trial: a review of trials of antibiotic prophylaxis. Arch Surg 1984;119:109–13.PubMedGoogle Scholar
  25. 25.
    Gardner MJ, Machin D, Campbell MJ. Use of check lists in assessing the statistical content of medical studies. In: Gardner MJ, Altman DG, eds. Statistics with confidence— Confidence intervals and statistical guidelines. London, England: Br Med J 1989;101–8.Google Scholar
  26. 26.
    Fletcher RH, Fletcher SW. Clinical rsearch in general medical journals: a 30-year perspective. N Engl J Med 1979;301:180–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Jadad AR, Moore RA, Carroll D et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.PubMedCrossRefGoogle Scholar
  28. 28.
    Altman DG. The scandal of poor medical research: we need less research, better research, and research done for the right reasons. Br Med J, 1994;308:283–4.Google Scholar
  29. 29.
    Altman DG, Dore C. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335:149–53.PubMedCrossRefGoogle Scholar
  30. 30.
    Pocock SJ, Hughes MD, Lee RJ. Statstical problems in the reporting of clinical trials: a survey of three medical journals. N Engl J Med 1987;317:426–32.PubMedGoogle Scholar
  31. 31.
    Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989;10:31–56 Correction: Control Clin Trials 1989;10:356PubMedCrossRefGoogle Scholar

Copyright information

© Urban & Vogel 1997

Authors and Affiliations

  • J. Köbberling
    • 1
  • Wilhelm Gaus
    • 2
  • Franz Porzsolt
    • 2
  1. 1.Wuppertal
  2. 2.Universität Ulm (Übersetzer)UlmDeutschland

Personalised recommendations